Protein Arginine Methyltransferase (PRMT) Inhibitors—AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures
Rhabdomyosarcoma (RMS) is a malignant soft tissue cancer that develops mostly in children and young adults. With regard to histopathology, four rhabdomyosarcoma types are distinguishable: embryonal, alveolar, pleomorphic and spindle/sclerosing. Currently, increased amounts of evidence indicate that...
Main Authors: | Joanna Janisiak, Patrycja Kopytko, Marta Tkacz, Dorota Rogińska, Magdalena Perużyńska, Bogusław Machaliński, Andrzej Pawlik, Maciej Tarnowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/8023 |
Similar Items
-
KAP1 is a Novel Substrate for the Arginine Methyltransferase PRMT5
by: Roberta di Caprio, et al.
Published: (2015-01-01) -
A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes
by: Iredia D. Iyamu, et al.
Published: (2021-06-01) -
Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations
by: Yufei Yue, et al.
Published: (2015-05-01) -
The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation and the Expression of MITF and p27Kip1 in Human Melanoma
by: Nicholas, Courtney
Published: (2012) -
Rhabdomyosarcoma from uterus to heart
by: Sohaib Roomi, et al.
Published: (2020-05-01)